Close

PPHM Financial Facts

Total revenues: 5.61M
Research and development: 8.57M
See Full Income Statement

Other assets: 2.5M
Total current liabilities: 63.26M
See Full Balance Sheet

Peregrine Pharmaceuticals Inc. (PPHM) Earnings

  |   Expand Research on PPHM
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -18.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS 0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
9/11/17 Q118 -$0.06-$0.12 +$0.06$27.07M$15.2M = Details
7/14/17 Q417 -$0.16N/A N/A $17.9M$18.78M = Details
3/13/17 Q317 -$0.04-$0.03 -$0.01$10.75M$14M = Details
12/12/16 Q217 N/A-$0.03 N/A $23.37M$17.98M = N/A N/A
9/8/16 Q117 -$0.05-$0.04 -$0.01$5.61M$13.09M = Details
7/14/16 Q416 -$0.05-$0.03 -$0.02$18.78M$15.8M = Details
3/9/16 Q316 -$0.08-$0.07 -$0.01$6.71M$7.96M N/A Details
12/10/15 Q216 -$0.07-$0.09 +$0.02$9.52M$7.5M N/A Details